AEYE Health AEYE Health announced it received FDA clearance for AEYE-DS — the industry's only portable, fully autonomous AI solution for diabetic retinopathy screening. The device diagnoses DR using one image per eye with over 99% imageability rate, no ophthalmologist required.
Press & Media
News & Press Releases
The latest announcements, partnerships, clinical milestones, and media coverage from AEYE Health.
Featured story
Latest news
TIME Magazine named AEYE Health's CEO to the 2024 TIME100 AI list, recognizing the 100 most influential individuals in artificial intelligence globally.
TIME Magazine named AEYE Health's CEO to the 2024 TIME100 AI list, recognizing the 100 most influential individuals in artificial intelligence globally.
TIME Magazine named AEYE Health's CEO to the 2024 TIME100 AI list, recognizing the 100 most influential individuals in artificial intelligence globally.
TIME Magazine named AEYE Health's CEO to the 2024 TIME100 AI list, recognizing the 100 most influential individuals in artificial intelligence globally.
TIME Magazine named AEYE Health's CEO to the 2024 TIME100 AI list, recognizing the 100 most influential individuals in artificial intelligence globally.
TIME Magazine named AEYE Health's CEO to the 2024 TIME100 AI list, recognizing the 100 most influential individuals in artificial intelligence globally.
TIME Magazine named AEYE Health's CEO to the 2024 TIME100 AI list, recognizing the 100 most influential individuals in artificial intelligence globally.
TIME Magazine named AEYE Health's CEO to the 2024 TIME100 AI list, recognizing the 100 most influential individuals in artificial intelligence globally.
TIME Magazine named AEYE Health's CEO to the 2024 TIME100 AI list, recognizing the 100 most influential individuals in artificial intelligence globally.
No news in this category yet.
Press room
Media Inquiries & Press Resources
For media inquiries, interview requests, or access to press materials, imagery, and executive bios, please reach out to our communications team. We aim to respond within one business day.
-
Brand Assets
Logos, product images, and brand guidelines for media use.
Request by email -
Executive Bios
Headshots and bios for leadership team and medical board.
Request by email -
Press Kit
Complete press kit including company overview and key facts.
Request by email -
FDA Clearance Docs
Official FDA De Novo K231169 clearance documentation.
Request by email
Get started
Turn every routine diabetic
visit into a completed eye exam
See AEYE-DS in a 30-minute demo tailored to your clinic's workflow, EHR setup, and
patient population.
FDA-cleared · No obligation · Tailored to your EHR